Literature DB >> 20466350

Weighing the risks and benefits of cardiac imaging with ionizing radiation.

Thomas C Gerber, Raymond J Gibbons.   

Abstract

The potential risk of fatal malignancy related to cardiac imaging with ionizing radiation is frequently discussed in the medical literature and in the lay press. Clinicians must weigh this risk against the potential benefits of cardiac imaging, which are typically not considered in these reports about radiation risk. This review summarizes the evidence regarding both the radiation risks and clinical benefits of cardiac imaging to provide guidance to the clinician in specific clinical scenarios. Choosing the right test for the right patient, and performing it with the lowest possible radiation dose, remains a challenge. Copyright 2010 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20466350     DOI: 10.1016/j.jcmg.2010.03.003

Source DB:  PubMed          Journal:  JACC Cardiovasc Imaging        ISSN: 1876-7591


  16 in total

Review 1.  Cell tracking and the development of cell-based therapies: a view from the Cardiovascular Cell Therapy Research Network.

Authors:  Martin Rodriguez-Porcel; Marvin W Kronenberg; Timothy D Henry; Jay H Traverse; Carl J Pepine; Stephen G Ellis; James T Willerson; Lemuel A Moyé; Robert D Simari
Journal:  JACC Cardiovasc Imaging       Date:  2012-05

2.  Strategies for defining an optimal risk-benefit ratio for stress myocardial perfusion SPECT.

Authors:  Reza Fazel; Vasken Dilsizian; Andrew J Einstein; Edward P Ficaro; Milena Henzlova; Leslee J Shaw
Journal:  J Nucl Cardiol       Date:  2011-05       Impact factor: 5.952

Review 3.  Serious and potentially life threatening complications of cardiac stress testing: Physiological mechanisms and management strategies.

Authors:  Vasken Dilsizian; Henry Gewirtz; Nicholas Paivanas; Anastasia N Kitsiou; Fadi G Hage; Nathan E Crone; Ronald G Schwartz
Journal:  J Nucl Cardiol       Date:  2015-05-15       Impact factor: 5.952

4.  Some remarks to SEOM clinical guidelines on cardiovascular toxicity (2018).

Authors:  F J de Haro-Del Moral; I Casans-Tormo; V Pubul-Nuñez; S Aguadé-Bruix
Journal:  Clin Transl Oncol       Date:  2019-05-29       Impact factor: 3.405

5.  Cardiovascular PET/MR: "Not the end but the beginning".

Authors:  Thomas Hellmut Schindler
Journal:  J Nucl Cardiol       Date:  2017-01-26       Impact factor: 5.952

Review 6.  Cardio-oncology: the Nuclear Option.

Authors:  Jorge A Alvarez; Raymond R Russell
Journal:  Curr Cardiol Rep       Date:  2017-04       Impact factor: 2.931

7.  Coronary calcium scans and radiation exposure in the multi-ethnic study of atherosclerosis.

Authors:  Bradley Messenger; Dong Li; Khurram Nasir; J Jeffrey Carr; Ron Blankstein; Matthew J Budoff
Journal:  Int J Cardiovasc Imaging       Date:  2015-10-29       Impact factor: 2.357

8.  Reduced administered activity, reduced acquisition time, and preserved image quality for the new CZT camera.

Authors:  Jenny Oddstig; Fredrik Hedeer; Jonas Jögi; Marcus Carlsson; Cecilia Hindorf; Henrik Engblom
Journal:  J Nucl Cardiol       Date:  2012-11-10       Impact factor: 5.952

Review 9.  The Challenges of Prevention, Diagnosis and Treatment of Ischemic Heart Disease in Women.

Authors:  LaPrincess C Brewer; Anna Svatikova; Sharon L Mulvagh
Journal:  Cardiovasc Drugs Ther       Date:  2015-08       Impact factor: 3.727

10.  Development and validation of a patient-tailored dose regime in myocardial perfusion imaging using CZT-SPECT.

Authors:  J D van Dijk; P L Jager; M Mouden; C H Slump; J P Ottervanger; J de Boer; A H J Oostdijk; J A van Dalen
Journal:  J Nucl Cardiol       Date:  2014-07-09       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.